CompuGroup Medical (UK) Insiders
0MSD Stock | 14.25 0.30 2.15% |
CompuGroup Medical employs about 8.4 K people. The company is managed by 14 executives with a total tenure of roughly 19628 years, averaging almost 1402.0 years of service per executive, having 600.86 employees per reported executive. Breaking down CompuGroup Medical's management performance can provide insight into the firm performance.
Daniel Gotthardt CEO CEO MD |
MBA LLM CEO CFO, CEO |
CompuGroup |
CompuGroup Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0305 % which means that it generated a profit of $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0379 %, meaning that it generated $0.0379 on every $100 dollars invested by stockholders. CompuGroup Medical's management efficiency ratios could be used to measure how well CompuGroup Medical manages its routine affairs as well as how well it operates its assets and liabilities. Total Assets is likely to drop to about 988.6 M in 2024. Non Current Assets Total is likely to drop to about 787 M in 2024Common Stock Shares Outstanding is likely to gain to about 55.5 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 71.2 M in 2024.
CompuGroup Medical Workforce Comparison
CompuGroup Medical AG is number one stock in number of employees category among its peers. The total workforce of Industrials industry is presently estimated at about 8,426. CompuGroup Medical totals roughly 8,412 in number of employees claiming about 100% of equities under Industrials industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. CompuGroup Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CompuGroup Medical Price Series Summation is a cross summation of CompuGroup Medical price series and its benchmark/peer.
CompuGroup Medical Notable Stakeholders
A CompuGroup Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CompuGroup Medical often face trade-offs trying to please all of them. CompuGroup Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CompuGroup Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel Gotthardt | CEO MD | Profile | |
MBA LLM | CFO, CEO | Profile | |
Angela Teufer | Connectivity DACH | Profile | |
Ulrich Thome | MD Board | Profile | |
Daniela Hommel | Chief Officer | Profile | |
Emanuele Mugnani | MD Board | Profile | |
Helge Wei | Senior Connectivity | Profile | |
Hannes Reichl | MD Board | Profile | |
Alexander Weimer | Head Communications | Profile | |
Michael Franz | Co Communication | Profile | |
Oliver Bruzek | Chief Affairs | Profile | |
Stefanie Peters | Member SE | Profile | |
Claudia Thom | Corporate Relations | Profile | |
Eckart Pech | MD Board | Profile |
About CompuGroup Medical Management Performance
The success or failure of an entity such as CompuGroup Medical often depends on how effective the management is. CompuGroup Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CompuGroup management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CompuGroup management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CompuGroup Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in CompuGroup Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CompuGroup Medical AG. Check CompuGroup Medical's Beneish M Score to see the likelihood of CompuGroup Medical's management manipulating its earnings.
CompuGroup Medical Workforce Analysis
Traditionally, organizations such as CompuGroup Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CompuGroup Medical within its industry.CompuGroup Medical Manpower Efficiency
Return on CompuGroup Medical Manpower
Revenue Per Employee | 141.2K | |
Revenue Per Executive | 84.8M | |
Net Income Per Employee | 5.6K | |
Net Income Per Executive | 3.3M |
Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.